Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ted R Mikuls

Showing results (291-300 of 351) with videos related to

Pageof 36
Sort By:
Arthritis Care & Research|June 30, 2025
Development and External Validation of a Genetic Risk Score for Pain in Rheumatoid ArthritisKatie J McMenamin, Thomas R Riley, Kristin Wipfler, et al.
Rheumatology (Oxford, England)|January 20, 2024
Development and internal validation of a clinical and genetic risk score for rheumatoid arthritis-associated interstitial lung diseaseAustin M Wheeler, Joshua F Baker, Thomas Riley, et al.
Rheumatology (Oxford, England)|December 14, 2025
Systemic inflammation in gout and the impact of treat-to-target urate-lowering therapyAustin M Wheeler, Tanner J Ourada, Spencer Q Jones, et al.
Rheumatology (Oxford, England)|September 16, 2015
Lower omega-3 fatty acids are associated with the presence of anti-cyclic citrullinated peptide autoantibodies in a population at risk for future rheumatoid arthritis: a nested case-control studyRyan W Gan, Kendra A Young, Gary O Zerbe, et al.
Annals of the Rheumatic Diseases|September 24, 2025
Use of statins and its association with major adverse cardiovascular events with tofacitinib vs TNF inhibitors in patients with rheumatoid arthritis with and without atherosclerotic cardiovascular diseaseJon T Giles, Christina Charles-Schoeman, Maya H Buch, et al.
Annals of the Rheumatic Diseases|May 19, 2016
Omega-3 fatty acids are associated with a lower prevalence of autoantibodies in shared epitope-positive subjects at risk for rheumatoid arthritisRyan W Gan, M Kristen Demoruelle, Kevin D Deane, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 7, 2025
Serum Proteomic Signatures Before the Diagnosis of Rheumatoid Arthritis: Evolving Biologic Pathways and Specific Periods of Disease DevelopmentSamir Rachid Zaim, Adam K Savage, Mark A Gillespie, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 30, 2019
Timing of Elevations of Autoantibody Isotypes Prior to Diagnosis of Rheumatoid ArthritisLindsay B Kelmenson, Brandie D Wagner, Bryan K McNair, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 1, 2020
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 2Ted R Mikuls, Sindhu R Johnson, Liana Fraenkel, et al.
International Immunopharmacology|August 30, 2021
The impact of airborne endotoxin exposure on rheumatoid arthritis-related joint damage, autoantigen expression, autoimmunity, and lung diseaseTed R Mikuls, Rohit Gaurav, Geoffrey M Thiele, et al.
Pageof 36

Showing results (291-300 of 351) with videos related to

Sort By:
Pageof 36
Arthritis Care & Research|June 30, 2025
Development and External Validation of a Genetic Risk Score for Pain in Rheumatoid ArthritisKatie J McMenamin, Thomas R Riley, Kristin Wipfler, et al.
Rheumatology (Oxford, England)|January 20, 2024
Development and internal validation of a clinical and genetic risk score for rheumatoid arthritis-associated interstitial lung diseaseAustin M Wheeler, Joshua F Baker, Thomas Riley, et al.
Rheumatology (Oxford, England)|December 14, 2025
Systemic inflammation in gout and the impact of treat-to-target urate-lowering therapyAustin M Wheeler, Tanner J Ourada, Spencer Q Jones, et al.
Rheumatology (Oxford, England)|September 16, 2015
Lower omega-3 fatty acids are associated with the presence of anti-cyclic citrullinated peptide autoantibodies in a population at risk for future rheumatoid arthritis: a nested case-control studyRyan W Gan, Kendra A Young, Gary O Zerbe, et al.
Annals of the Rheumatic Diseases|September 24, 2025
Use of statins and its association with major adverse cardiovascular events with tofacitinib vs TNF inhibitors in patients with rheumatoid arthritis with and without atherosclerotic cardiovascular diseaseJon T Giles, Christina Charles-Schoeman, Maya H Buch, et al.
Annals of the Rheumatic Diseases|May 19, 2016
Omega-3 fatty acids are associated with a lower prevalence of autoantibodies in shared epitope-positive subjects at risk for rheumatoid arthritisRyan W Gan, M Kristen Demoruelle, Kevin D Deane, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 7, 2025
Serum Proteomic Signatures Before the Diagnosis of Rheumatoid Arthritis: Evolving Biologic Pathways and Specific Periods of Disease DevelopmentSamir Rachid Zaim, Adam K Savage, Mark A Gillespie, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 30, 2019
Timing of Elevations of Autoantibody Isotypes Prior to Diagnosis of Rheumatoid ArthritisLindsay B Kelmenson, Brandie D Wagner, Bryan K McNair, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 1, 2020
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 2Ted R Mikuls, Sindhu R Johnson, Liana Fraenkel, et al.
International Immunopharmacology|August 30, 2021
The impact of airborne endotoxin exposure on rheumatoid arthritis-related joint damage, autoantigen expression, autoimmunity, and lung diseaseTed R Mikuls, Rohit Gaurav, Geoffrey M Thiele, et al.
Pageof 36